Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001628280-20-007974
Filing Date
2020-05-18
Accepted
2020-05-18 16:28:05
Documents
2
Effectiveness Date
2020-05-18

Document Format Files

Seq Description Document Type Size
1 DEFA14A defa14a_virtualannualmeeti.htm DEFA14A 43952
2 portolalog.jpg GRAPHIC 12016
  Complete submission text file 0001628280-20-007974.txt   61646
Mailing Address 270 EAST GRAND AVENUE, SUITE 22 SOUTH SAN FRANCISCO CA 94080
Business Address 270 EAST GRAND AVENUE, SUITE 22 SOUTH SAN FRANCISCO CA 94080 650-244-6864
PORTOLA PHARMACEUTICALS INC (Filer) CIK: 0001269021 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35935 | Film No.: 20889921
SIC: 2834 Pharmaceutical Preparations